Source: International Congress 2018 – What is new in idiopathic interstitial pneumonias?



Rating:

Share or cite this content

Citations should be made in the following way:
E. Gorina (San Francisco, United States of America), T. Sekayan (San Francisco, United States of America), J. Swigris (Denver, United States of America), P. Lacamera (Boston, United States of America), R. Perez (Louisville, United States of America), M. Hamblin (Kansas City, United States of America), J. Deandrade (Birmingham, United States of America), J. Fitzgerald (Dallas, United States of America), P. Bercz (Pensacola, United States of America), M. Zhong (San Francisco, United States of America), E. Kouchakji (San Francisco, United States of America), P. Yu (San Francisco, United States of America), T. Neff (San Francisco, United States of America). Effect of pamrevlumab on the UCSD-SOBQ (University of California San Diego–Shortness of Breath Questionnaire) in patients with Idiopathic Pulmonary Fibrosis (IPF). 5239

Member's Comments

No comment yet.

Related content which might interest you: Clinical characteristics of familial Idiopathic Pulmonary Fibrosis (f-IPF) at the University of Giessen Marburg Lung Center. Source: International Congress 2018 – Idiopathic interstital pneumonias other than idiopathic pulmonary fibrosis (IPF) Year: 2018 Association between severity of Idiopathic Pulmonary Fibrosis and air Pollution levels in Madrid Source: Virtual Congress 2021 – Interstitial lung disease around the world Year: 2021 Lung Clearance Index (LCI) in children = 12 years old with Cystic Fibrosis (CF) taking ORKAMBI at University Hospital Limerick (UHL) Source: International Congress 2018 – Evolving approaches to differential diagnosis Year: 2018 Sporadic and TSC-related lymphangioleiomyomatosis (LAM): The experience of Ospedale San Paolo of Milan (preliminary data) Source: International Congress 2014 – ILDs 3 Year: 2014 Association between mortality of Idiopathic Pulmonary Fibrosis and air Pollution levels in Madrid Source: Virtual Congress 2021 – Interstitial lung disease around the world Year: 2021 Effects of Pulmonary Rehabilitation (PR) on Exercise Capacity (EC) and Quality of Life (QOL) in Indian Patients with Severe COPD Source: International Congress 2017 – Latest insights into pulmonary rehabilitation in COPD Year: 2017 Evaluation of Dyspnea Questionnaires in Patients with Idiopathic Pulmonary Fibrosis (IPF). Source: International Congress 2018 – Consequences of idiopathic interstitial pneumonias Year: 2018 The Italian Reference Center Database for Pulmonary Alveolar Proteinosis (PAP). Source: International Congress 2017 – Rare diseases Year: 2017 Role of the PE rule-out criteria (PERC) in patients with suspected pulmonary embolism (PE) in a UK District General Hospital Source: International Congress 2016 – Acute pulmonary embolism Year: 2016 Clinical picture analysis of idiopathic pulmonary fibrosis (IPF) and lung cancer (LC) concomitance in the population of patients hospitalized in Ist Clinic of Lung Diseases Institute for Tuberculosis and Lung Diseases in Warsaw, Poland in the years 1994-2009 Source: Annual Congress 2011 - What is new in the approach to pulmonary fibrosis? Year: 2011 Agreement Between COPD Assessment Test (CAT) And Modified Medical Research Council (mMRC) Dyspnea Scores For GOLD COPD Classification: A Cross-Sectional Analyses Source: International Congress 2019 – Clinical implications of COPD management Year: 2019 Moleculer characterization of severe allergic asthma patients via exhaled breath volatile organic compounds(Ege University Translational Pulmonology Research Group [EgeTPRG]) Source: International Congress 2017 – Monitoring asthma control Year: 2017 Clinical Correlates of Physical Activity in Idiopathic Pulmonary Fibrosis (IPF) Source: International Congress 2019 – Pulmonary rehabilitation for non-obstructive lung diseases Year: 2019 An audit of adherence to Two-Level Well’s Score in patients hospitalized with Sars-Co-V-2 with suspected Pulmonary Emboli in a University Hospital. Source: Virtual Congress 2021 – Pulmonary embolism in non-COVID-19 and COVID-19 patients Year: 2021 Outcome of Nasal High Flow Nasal Oxygen Therapy (HFNO) in Acute Hypoxemic Respiratory Failure (AHRF) on an Acute Respiratory Care Unit (ARCU) Source: Sleep and Breathing Conference 2021 Year: 2021 Survival in CVD-ILD at Ege University Hospital Source: International Congress 2016 – Connective tissue disorders Year: 2016 Phenotyping Adults with Non-Cystic Fibrosis Bronchiectasis:A 5-Year Cohort Study in a Azerbaijan medical University Center Source: International Congress 2017 – Clinical challenges in chronic lung diseases Year: 2017 Retrospective analysis of patients with diffuse parenchimal lung diseases (dpld) admitted to San Camillo-Forlanini Hospital in Rome (Italy) Source: Annual Congress 2009 - Various backgrounds in diffuse parenchymal lung disease Year: 2009 Comorbidities in 1779 sarcoidosis patients – 4 years experience in National Tuberculosis and Lung Diseases Research Institute in Warsaw, Poland Source: Annual Congress 2012 - Respiratory manifestations of systemic disease: a holistic approach Year: 2012